the first precision medicine approach to pain
The R&D Problem
Current treatments have limited efficacy with serious side effects and abuse potential
There is a severe lack of innovation in pain R&D
Pain has a very high (98%) attrition rate in clinical drug development
Many established players left research
We believe there are two key reasons for the lack of innovation in pain;
The approach to pain R&D has not changed in 20 years with a reliance on non-translatable preclinical models and no 'target-to-disease' link established for research projects
Our Unique Solution
We have developed the first precision medicine approach to pain to create more effective treatments and increase clinical success.
Our novel bioinformatic network biology approach to research connected to our proprietary pain landscape database of 100’s of diseases allows us to link research targets to disease and significantly de-risked R&D.
Find out more about our technology
Our Personalized Analgesics® research platform brings together a network of databases linking drug targets, genetic and biological pathways to pain related diseases.